TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Integrativ Biomedicin Öckerman AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
514
|
440 | |
| Financial expenses |
1
|
0 | |
| Earnings before taxes |
222
|
-28 | |
| EBITDA |
122
|
-123 | |
| Total assets |
745
|
670 | |
| Current assets |
720
|
646 | |
| Current liabilities |
42
|
16 | |
| Equity capital |
684
|
642 | |
| - share capital |
101
|
95 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
91.8%
|
95.8% | |
| Turnover per employee |
514
|
440 | |
| Profit as a percentage of turnover |
43.2%
|
-6.4% | |
| Return on assets (ROA) |
29.9%
|
-4.2% | |
| Current ratio |
1714.3%
|
4037.5% | |
| Return on equity (ROE) |
32.5%
|
-4.4% | |
| Change turnover |
43
|
-17 | |
| Change turnover % |
-17%
|
9%
|
-4% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.